Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Moderate-to-Severe Acute Pain. Show all posts
Showing posts with label Moderate-to-Severe Acute Pain. Show all posts
Monday, November 3, 2025

FDA Approves Journavx (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

›
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)   announced   U.S. Food and Drug Administration (FDA)   approval of  Journavx (suzetrigin...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.